期刊文献+

强直性脊柱炎患者血清Dickkopf-1、抗酒石酸酸性磷酸酶5b的意义 被引量:1

Dickkopf-1 and Tartrate-Resistant Acid Phosphatase 5b in Ankylosing Spondylitis
下载PDF
导出
摘要 目的:通过测定强直性脊柱炎(AS)患者血清Dickkopf-1(DKK-1)、抗酒石酸酸性磷酸酶5b(TRACP-5b)的水平,分析AS各项临床指标与DKK-1、TRACP-5b的相关性,探讨AS骨结构损伤的特点。方法记录30例AS患者的年龄、性别、病程、HLA-B27及治疗前后晨僵、脊柱痛、枕壁距、指地距、血沉(ESR)、C反应蛋白(CRP)、Bath AS疾病活动指数(BASDAI)、骶髂关节CT分级,以酶联免疫吸附法(ELISA)测定研究对象血清DKK-1、TRACP-5b的水平,对比AS患者与健康对照组血清DKK-1、TRACP-5b水平的差异,并分析其与AS各项临床指标的相关性。结果1.AS患者的血清DKK-1、TRACP-5b水平分别为819.65±204.56 pg/mL、3.9393±1.3354 U/L,均低于健康对照组(1591.50±335.92 pg/mL、8.6379±1.9148 U/L),差异有统计学意义(P<0.05);2.早期AS患者血清DKK-1、TRACP-5b水平分别为1186.00±493.70 pg/mL、5.9150±2.9282 U/L,均高于中晚期AS患者(636.60±181.04 pg/mL、2.9614±1.3772 U/L),但差异无统计学意义(P>0.05);3.AS患者血清DKK-1、TRACP-5b均与患者骶髂关节CT分级呈负相关(P<0.05),与其他临床指标均不相关;4.AS患者血清DKK-1、TRACP-5b呈正相关(P<0.0001)。结论DKK-1、TRACP-5b在AS骨结构损伤发生中可能起了一定的作用。 Objective To detect the serum levels of dickkopf-1 (DKK-1) and tartrate-resistant acid phosphatase 5b (TRACP-5b) in patients with ankylosing spondylitis (AS) and investigate the possible role of DKK-1 and TRACP-5b in structural damage of AS. Methods ELISA was used to detect the levels of DKK-1 and TRACP-5b. The core indicators of AS were evaluated to contrast the serum levels of DKK-1 and TRACP-5b in two groups and analyze the relevance of DKK-1, TRACP-5b and the core indexes of AS. Results 1.The levels of serum DKK-1 and TRACP-5b in AS were 819.65±204.56 pg/mL and 3.9393±1.3354 U/L, significantly lower than which in control group (1591.50±335.92 pg/mL and 8.6379±1.9148 U/L, P〈0.05);2.The levels of serum DKK-1 and TRACP-5b of early AS were 1186.00±493.70 pg/mL and 5.9150±2.9282 U/L, higher than that of medium and late AS (636.60±181.04 pg/mL and 2.9614±1.3772 U/L), but there was no significance between them (P〉0.05);3.The levels of serum DKK-1 and TRACP-5b were both negatively correlated with the radiographic stage in patients with AS (P〈0.05);4.There was positive correlation between the level of serum DKK-1 and TRACP-5b in patients with AS (P〈0.0001). Conclusion DKK-1 and TRACP-5b may play role in AS.
出处 《中国血液流变学杂志》 CAS 2014年第3期383-386,共4页 Chinese Journal of Hemorheology
关键词 强直性脊柱炎 DICKKOPF-1 抗酒石酸酸性磷酸酶5B ankylosing spondylitis Dickkopf-1 tartrate-resistant acid phosphatase 5b
  • 相关文献

参考文献9

  • 1Pinzone JJ, Hall BM, Thudi NK, et al. The role of Dickkopf-1 in bone development, homeostasis, and disease[J]. Blood, 2009, 113(3): 517 - 525.
  • 2van der Heijde D, Salonen D, Weissman BN, et al. Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years[J]. Arthritis Res Ther, 2009, 11(4): Rl27.
  • 3赵伟,黄烽.破骨细胞在强直性脊柱炎滑膜组织中的分化及其在外周关节骨质破坏病理机制中的作用[J].解放军医学杂志,2005,30(11):981-984. 被引量:7
  • 4Im CH, Kang EH, Ki JY, et al. Receptor activator of nuclear factor kappa B ligand-mediated osteoclastogenesis is elevated in ankylosing spondylitis[J]. Clin Exp Rheumatol, 2009, 27(4): 620 - 625.
  • 5Zhang M, Yah Y, Lirn YB, et al. BMP-2 modulates beta- catenin signaling through stimulation of Lrp5 expression and inhibition of beta-TrCP expression in osteoblasts[J]. J Cell Biochem, 2009, 108(4): 896 - 905.
  • 6Diarra D, Stolina M, Polzer K, et al. Dickkopf-1 is a master regulator of joint remodeling[J]. Nat Med, 2007, 13(2): 156 ~ 163.
  • 7Kwon SR, Lim MJ, Suh CH, et al. Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy[J]. Rheumatol Int, 2012, 32(8): 2523 - 2527.
  • 8Maksymowych WP. What do biomarkers tell us about the pathogenesis of ankylosing spondylitis?[J]. Arthritis Res Ther, 2009, 11(1): 101.
  • 9Lories RJ, Derese I, de Bari C, et al. Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis[J]. Arthritis Rheum, 2007, 56(2): 489 - 497.

二级参考文献8

  • 1Maksymowych WP. Ankylosing spondylitis-at the interface of bone and cartilage. J Rheumatol, 2000, 27:2295
  • 2Braun J, Bollow M, Sieper J. Radiologic diagnosis and pathology of the spondyloarthropathies. Rheum Dis Clin North Am, 1998, 24:697
  • 3Danks L, Sabokbar A, Gundle R et al. Synovial macrophage-osteoclast differentiation in inflammatory arthritis. Ann Rheum Dis, 2002,61:916
  • 4Fujikawa Y, Shingu M, Torisu T et al. Bone resorption by tartrate-resistant acid phosphatase-positive multinuclear cells isolated from rheumatoid synovium. Br J Rheumatol, 1996, 35:213
  • 5Udagawa N, Takahashi N, Akatsu T et al. Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci USA, 1990, 87:7260
  • 6Takayanagi H, Iizuka H, Juji T et al. involvement of receptor activator of nuclear factor-κB ligand osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum, 2000, 43:259
  • 7Mori H, Kitazawa R, Mizuki S et al. RANK ligand, RANK, and OPG expression in type II collagen-induced arthritis mouse. Histochem Cell Biol, 2002, 117(3):283
  • 8赵伟,黄烽.细胞核因子κB受体活化因子配基在强直性脊柱炎的表达及意义[J].解放军医学杂志,2004,29(6):482-485. 被引量:26

共引文献6

同被引文献4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部